Pyrvinium targets autophagy addiction to promote cancer cell death

Longfei Deng1, Yunlong Lei, Rui Liu

  • 1The State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Insights

Pyrvinium pamoate, an antihelminthic drug, inhibits cancer cell autophagy by reducing gene expression. Combining pyrvinium with autophagy stimuli enhances its anticancer effects, suggesting a new therapeutic strategy targeting autophagy addiction.

Area of Science:

  • Cell Biology
  • Oncology
  • Pharmacology

Background:

  • Autophagy is a cellular process crucial for cancer cell survival under stress.
  • Pyrvinium pamoate, an antihelminthic, shows potential anticancer activity.
  • Understanding pyrvinium's mechanism is key to developing new cancer therapies.

Purpose of the Study:

  • To investigate the effect of pyrvinium pamoate on autophagy in cancer cells.
  • To elucidate the mechanism by which pyrvinium inhibits autophagy.
  • To evaluate the therapeutic potential of combining pyrvinium with autophagy-modulating agents.

Main Methods:

  • In vitro and in vivo studies using cancer cell lines.
  • Analysis of autophagy gene expression and mammalian target of rapamycin (mTOR) pathway.
  • Combination therapy studies with autophagy inducers like 2-deoxy-D-glucose (2-DG) and inhibitors like 3-MA.

Main Results:

  • Pyrvinium pamoate effectively inhibits autophagy in cancer cells, independent of mTOR.
  • Inhibition of autophagy by pyrvinium occurs via transcriptional downregulation of autophagy genes.
  • Combination of pyrvinium with autophagy stimuli (e.g., 2-DG) significantly enhances cancer cell toxicity and inhibits tumor growth in vivo.
  • Evidence suggests cancer cells can become addicted to autophagy, making them vulnerable to pyrvinium.

Conclusions:

  • Pyrvinium pamoate is a potent autophagy inhibitor with anticancer properties.
  • Targeting autophagy addiction with pyrvinium offers a novel therapeutic strategy.
  • Combination therapy of pyrvinium with other anticancer agents or autophagy inducers may improve treatment efficacy.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...